Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Stephans

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
European Urology|April 8, 2023
Disparities in Prostate Cancer Diagnoses Among Persons Experiencing HomelessnessZachary S Mayo, Sean M Parker, Sarah S Kilic, et al.
Practical Radiation Oncology|April 23, 2015
Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitisSheen Cherian, Jeffrey A Kittel, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient OutcomesRupesh Kotecha, Toufik Djemil, Rahul D Tendulkar, et al.
Journal of Medical Imaging and Radiation Oncology|February 6, 2018
Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair studyTingliang Zhuang, Neil M Woody, Han Liu, et al.
Cancers|September 28, 2021
A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation TherapyMark K Farrugia, Han Yu, Gregory M Videtic, et al.
JCO Oncology Practice|October 7, 2022
Prostate Cancer Screening Disparities in Persons Experiencing HomelessnessZachary S Mayo, Sarah S Kilic, Jeremy Weleff, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2019
Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate CancerIbrahim Abu-Gheida, Chandana A Reddy, Rupesh Kotecha, et al.
American Journal of Clinical Oncology|April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot StudyShireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Cancers|February 15, 2022
Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and DoneAustin J Bartl, Mary Mahoney, Mark W Hennon, et al.
JTO Clinical and Research Reports|July 11, 2022
A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLCChristopher A Lemmon, Gregory M M Videtic, Sudish Murthy, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
European Urology|April 8, 2023
Disparities in Prostate Cancer Diagnoses Among Persons Experiencing HomelessnessZachary S Mayo, Sean M Parker, Sarah S Kilic, et al.
Practical Radiation Oncology|April 23, 2015
Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitisSheen Cherian, Jeffrey A Kittel, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient OutcomesRupesh Kotecha, Toufik Djemil, Rahul D Tendulkar, et al.
Journal of Medical Imaging and Radiation Oncology|February 6, 2018
Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair studyTingliang Zhuang, Neil M Woody, Han Liu, et al.
Cancers|September 28, 2021
A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation TherapyMark K Farrugia, Han Yu, Gregory M Videtic, et al.
JCO Oncology Practice|October 7, 2022
Prostate Cancer Screening Disparities in Persons Experiencing HomelessnessZachary S Mayo, Sarah S Kilic, Jeremy Weleff, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2019
Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate CancerIbrahim Abu-Gheida, Chandana A Reddy, Rupesh Kotecha, et al.
American Journal of Clinical Oncology|April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot StudyShireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Cancers|February 15, 2022
Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and DoneAustin J Bartl, Mary Mahoney, Mark W Hennon, et al.
JTO Clinical and Research Reports|July 11, 2022
A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLCChristopher A Lemmon, Gregory M M Videtic, Sudish Murthy, et al.
Pageof 9